Abstract
Cardiac complications (perioperative myocardial infarction and cardiac death) are the leading cause of morbidity and mortality in patients undergoing major vascular surgery. The incidence of these complications has been reported to be up to 25%. Compared with open surgery, endovascular procedures are associated with fewer perioperative complications. However, long-term outcome is similar for both open and endovascular procedures, suggesting that long-term outcome is primarily related to the presence and extent of underlying coronary artery disease and not to the treatment modality. Patients requiring major aortic reconstruction need a thorough cardiovascular evaluation and risk stratification in order to assess the feasibility of surgery, the opportunity for preoperative myocardial revascularization or treatment of valvulopathies, the optimization of medical therapy, and the surgical approach. In particular, preoperative cardiac evaluation may help to identify high-risk patients in whom coronary angiography may be planned with subsequent coronary revascularization for the purpose of improving perioperative and long-term cardiac outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham N, Lemech L, Sandroussi C et al. A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms. J Vasc Surg 2005;41:377–380
Winkel TA, Schouten O, van Kuijk JP et al. Perioperative asymptomatic cardiac damage after endovascular abdominal aneurysm repair is associated with poor long-term outcome. J Vasc Surg 2009;50:749–754
Hertzer NR, Beven EG, Young JR et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984;199:223–233
Mangano DT, Browner WS, Hollenberg M et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990;323:1781–1788
Goldman L, Caldera DL, Nussbaum SR et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845–850
Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769–2812
Schouten O, Sillesen H, Poldermans D. New Guidelines from the European Society of Cardiology for Perioperative Cardiac Care: a summary of implications for elective vascular surgery patients. Eur J Vasc Endovasc Surg 2010;39:1–4
Rohde LE, Polanczyk CA, Goldman L et al. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 2001;87:505–509
Kertai MD, Boersma E, Bax JJ et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003;89:1327–1334
Pellikka PA, Roger VL, Oh JK et al. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter. Am J Cardiol 1996;77:413–416
Shaw LJ, Eagle KA, Gersh BJ et al. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996;27:787–798
Poldermans D, Bax JJ, Schouten O et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 2006;48:964–969
Stone JG, Foex P, Sear JW et al. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988;68:495–500
Devereaux PJ, Yang H, Yusuf S et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839–1847
Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742–752
Shchukin Iu V, Vachev AN, Surkova EA et al. [The role of beta-adrenoblockers and If-inhibitor ivabradine in lowering of rate of development of cardiac complications after carotid endarterectomy]. Kardiologiia 2008;48:56–59
Schouten O, Boersma E, Hoeks SE et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009;361:980–989
Schouten O, Hoeks SE, Welten GM et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007;100:316–320
McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795–2804
Poldermans D, Schouten O, Vidakovic R et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007;49:1763–1769
Monaco M, Stassano P, Di Tommaso L et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium-to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 2009;54:989–996
Domanski M, Ellis S, Eagle K. Does preoperative coronary revascularization before noncardiac surgery reduce the risk of coronary events in patients with known coronary artery disease? Am J Cardiol 1995; 75:829–831
Kaluza GL, Joseph J, Lee JR et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288–1294
van Kuijk JP, Flu WJ, Schouten O et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009;104:1229–1234
Savonitto S, D’Urbano M, Caracciolo M et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010;104:285–291
Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention — cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation — review and meta-analysis. J Intern Med 2005;257:399–414
Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001;93:573–580
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173–2195
Badner NH, Knill RL, Brown JE et al. Myocardial infarction after noncardiac surgery. Anesthesiology 1998;88:572–578
Landesberg G, Shatz V, Akopnik I et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003; 42:1547–1554
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Italia
About this chapter
Cite this chapter
Pappalardo, F., Melisurgo, G. (2011). Cardiovascular Evaluation, Risk Stratification, and Management of Postoperative Myocardial Infarction. In: Chiesa, R., Melissano, G., Zangrillo, A. (eds) Thoraco-Abdominal Aorta. Springer, Milano. https://doi.org/10.1007/978-88-470-1857-0_16
Download citation
DOI: https://doi.org/10.1007/978-88-470-1857-0_16
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1856-3
Online ISBN: 978-88-470-1857-0
eBook Packages: MedicineMedicine (R0)